Skip to main content
Fig. 2 | International Journal of Retina and Vitreous

Fig. 2

From: Short-term outcomes in patients with center-involving diabetic macular edema after a single dose of intravitreal bevacizumab

Fig. 2

Column charts illustrating mean change in BCVA and OCT metrics from baseline in response subgroups. The responder subgroup included 22 eyes and the non-responder subgroup 30 eyes. A Best-corrected visual acuity. B Central subfield thickness. C Total macular volume. P-values were derived from paired Student’s t-tests and Wilcoxon signed rank tests. Significant at p < 0.05

Back to article page